← All organizations
Highest phase reached
Phase 2
First clinical trial
Jan 31, 2025Last known activity
Jan 31, 2025
Acquired by Climb Bio, Inc. on Nov 1, 2024
Timeline
2020s
- Nov 1, 2024
Climb Bio, Inc.— Acquired By
Drugs by trial phase (1 distinct, 1 trials)
Phase 2 (1 own, 0 via acquisition)
Recent trials (1)
- NCT06570434Lead sponsorPhase 1/Phase 2Jan 31, 2025
Details
- Founded
- Scotch Plains, NJ, US
- Last known activity
- Jan 31, 2025